Synopsis
Synopsis
0
VMF
Annual Reports
NA
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Molecular Weight | 136.11 g/mol |
---|---|
Molecular Formula | C5H4N4O |
XLogP3 | -0.5 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 0 |
Exact Mass | 136.03851076 g/mol |
Monoisotopic Mass | 136.03851076 g/mol |
Topological Polar Surface Area | 65.8 A^2 |
Heavy Atom Count | 10 |
Formal Charge | 0 |
Complexity | 275 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
1 of 10 | |
---|---|
Drug Name | Allopurinol |
PubMed Health | Allopurinol |
Drug Classes | Antigout, Urinary Stone Agent |
Drug Label | Allopurinol is known chemically as 1,5-Dihydro-4H-pyrazolo[3,4-d ]pyrimidin-4-one. It is a xanthine oxidase inhibitor which is administered orally. Its solubility in water at 37C is 80 mg/dL and is greater in an alkaline solution. Allopurinol Table... |
Active Ingredient | Allopurinol |
Dosage Form | Tablet |
Route | Oral |
Strength | 300mg; 100mg |
Market Status | Prescription |
Company | Watson Labs; Vintage Pharms; Ipca Labs; Mutual Pharm; Apotex; Accord Hlthcare; Sun Pharm Inds; Northstar Hlthcare; Mylan |
2 of 10 | |
---|---|
Drug Name | Allopurinol sodium |
PubMed Health | Allopurinol (Injection) |
Drug Classes | Antigout, Urinary Stone Agent |
Drug Label | ALOPRIM (allopurinol sodium) for Injection is the brand name for allopurinol, a xanthine oxidase inhibitor. ALOPRIM (allopurinol sodium) for Injection is a sterile solution for intravenous infusion only. It is available in vials as the sterile lyophi... |
Active Ingredient | Allopurinol sodium |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 500mg base/vial |
Market Status | Prescription |
Company | Eurohlth Intl |
3 of 10 | |
---|---|
Drug Name | Aloprim |
PubMed Health | Allopurinol |
Drug Classes | Antigout, Urinary Stone Agent |
Drug Label | ZYLOPRIM (allopurinol) has the following structural formula:ZYLOPRIM is known chemically as 1,5-dihydro-4H-pyrazolo [3,4-d]pyrimidin-4-one. It is a xanthine oxidase inhibitor which is administered orally. Each scored white tablet contains 100 mg allo... |
Active Ingredient | Allopurinol sodium |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 500mg base/vial |
Market Status | Prescription |
Company | Mylan Institutional |
4 of 10 | |
---|---|
Drug Name | Lopurin |
Active Ingredient | Allopurinol |
Dosage Form | Tablet |
Route | Oral |
Strength | 300mg; 100mg |
Market Status | Prescription |
Company | Dr Reddys La |
5 of 10 | |
---|---|
Drug Name | Zyloprim |
Active Ingredient | Allopurinol |
Dosage Form | Tablet |
Route | Oral |
Strength | 300mg; 100mg |
Market Status | Prescription |
Company | Prometheus Labs |
6 of 10 | |
---|---|
Drug Name | Allopurinol |
PubMed Health | Allopurinol |
Drug Classes | Antigout, Urinary Stone Agent |
Drug Label | Allopurinol is known chemically as 1,5-Dihydro-4H-pyrazolo[3,4-d ]pyrimidin-4-one. It is a xanthine oxidase inhibitor which is administered orally. Its solubility in water at 37C is 80 mg/dL and is greater in an alkaline solution. Allopurinol Table... |
Active Ingredient | Allopurinol |
Dosage Form | Tablet |
Route | Oral |
Strength | 300mg; 100mg |
Market Status | Prescription |
Company | Watson Labs; Vintage Pharms; Ipca Labs; Mutual Pharm; Apotex; Accord Hlthcare; Sun Pharm Inds; Northstar Hlthcare; Mylan |
7 of 10 | |
---|---|
Drug Name | Allopurinol sodium |
PubMed Health | Allopurinol (Injection) |
Drug Classes | Antigout, Urinary Stone Agent |
Drug Label | ALOPRIM (allopurinol sodium) for Injection is the brand name for allopurinol, a xanthine oxidase inhibitor. ALOPRIM (allopurinol sodium) for Injection is a sterile solution for intravenous infusion only. It is available in vials as the sterile lyophi... |
Active Ingredient | Allopurinol sodium |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 500mg base/vial |
Market Status | Prescription |
Company | Eurohlth Intl |
8 of 10 | |
---|---|
Drug Name | Aloprim |
PubMed Health | Allopurinol |
Drug Classes | Antigout, Urinary Stone Agent |
Drug Label | ZYLOPRIM (allopurinol) has the following structural formula:ZYLOPRIM is known chemically as 1,5-dihydro-4H-pyrazolo [3,4-d]pyrimidin-4-one. It is a xanthine oxidase inhibitor which is administered orally. Each scored white tablet contains 100 mg allo... |
Active Ingredient | Allopurinol sodium |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 500mg base/vial |
Market Status | Prescription |
Company | Mylan Institutional |
9 of 10 | |
---|---|
Drug Name | Lopurin |
Active Ingredient | Allopurinol |
Dosage Form | Tablet |
Route | Oral |
Strength | 300mg; 100mg |
Market Status | Prescription |
Company | Dr Reddys La |
10 of 10 | |
---|---|
Drug Name | Zyloprim |
Active Ingredient | Allopurinol |
Dosage Form | Tablet |
Route | Oral |
Strength | 300mg; 100mg |
Market Status | Prescription |
Company | Prometheus Labs |
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
61
PharmaCompass offers a list of Allopurinol API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Allopurinol manufacturer or Allopurinol supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Allopurinol manufacturer or Allopurinol supplier.
PharmaCompass also assists you with knowing the Allopurinol API Price utilized in the formulation of products. Allopurinol API Price is not always fixed or binding as the Allopurinol Price is obtained through a variety of data sources. The Allopurinol Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Azupharma Brand of Allopurinol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Azupharma Brand of Allopurinol, including repackagers and relabelers. The FDA regulates Azupharma Brand of Allopurinol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Azupharma Brand of Allopurinol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Azupharma Brand of Allopurinol manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Azupharma Brand of Allopurinol supplier is an individual or a company that provides Azupharma Brand of Allopurinol active pharmaceutical ingredient (API) or Azupharma Brand of Allopurinol finished formulations upon request. The Azupharma Brand of Allopurinol suppliers may include Azupharma Brand of Allopurinol API manufacturers, exporters, distributors and traders.
click here to find a list of Azupharma Brand of Allopurinol suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Azupharma Brand of Allopurinol DMF (Drug Master File) is a document detailing the whole manufacturing process of Azupharma Brand of Allopurinol active pharmaceutical ingredient (API) in detail. Different forms of Azupharma Brand of Allopurinol DMFs exist exist since differing nations have different regulations, such as Azupharma Brand of Allopurinol USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Azupharma Brand of Allopurinol DMF submitted to regulatory agencies in the US is known as a USDMF. Azupharma Brand of Allopurinol USDMF includes data on Azupharma Brand of Allopurinol's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Azupharma Brand of Allopurinol USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Azupharma Brand of Allopurinol suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Azupharma Brand of Allopurinol Drug Master File in Japan (Azupharma Brand of Allopurinol JDMF) empowers Azupharma Brand of Allopurinol API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Azupharma Brand of Allopurinol JDMF during the approval evaluation for pharmaceutical products. At the time of Azupharma Brand of Allopurinol JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Azupharma Brand of Allopurinol suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Azupharma Brand of Allopurinol Drug Master File in Korea (Azupharma Brand of Allopurinol KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Azupharma Brand of Allopurinol. The MFDS reviews the Azupharma Brand of Allopurinol KDMF as part of the drug registration process and uses the information provided in the Azupharma Brand of Allopurinol KDMF to evaluate the safety and efficacy of the drug.
After submitting a Azupharma Brand of Allopurinol KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Azupharma Brand of Allopurinol API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Azupharma Brand of Allopurinol suppliers with KDMF on PharmaCompass.
A Azupharma Brand of Allopurinol CEP of the European Pharmacopoeia monograph is often referred to as a Azupharma Brand of Allopurinol Certificate of Suitability (COS). The purpose of a Azupharma Brand of Allopurinol CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Azupharma Brand of Allopurinol EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Azupharma Brand of Allopurinol to their clients by showing that a Azupharma Brand of Allopurinol CEP has been issued for it. The manufacturer submits a Azupharma Brand of Allopurinol CEP (COS) as part of the market authorization procedure, and it takes on the role of a Azupharma Brand of Allopurinol CEP holder for the record. Additionally, the data presented in the Azupharma Brand of Allopurinol CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Azupharma Brand of Allopurinol DMF.
A Azupharma Brand of Allopurinol CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Azupharma Brand of Allopurinol CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Azupharma Brand of Allopurinol suppliers with CEP (COS) on PharmaCompass.
A Azupharma Brand of Allopurinol written confirmation (Azupharma Brand of Allopurinol WC) is an official document issued by a regulatory agency to a Azupharma Brand of Allopurinol manufacturer, verifying that the manufacturing facility of a Azupharma Brand of Allopurinol active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Azupharma Brand of Allopurinol APIs or Azupharma Brand of Allopurinol finished pharmaceutical products to another nation, regulatory agencies frequently require a Azupharma Brand of Allopurinol WC (written confirmation) as part of the regulatory process.
click here to find a list of Azupharma Brand of Allopurinol suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Azupharma Brand of Allopurinol as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Azupharma Brand of Allopurinol API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Azupharma Brand of Allopurinol as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Azupharma Brand of Allopurinol and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Azupharma Brand of Allopurinol NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Azupharma Brand of Allopurinol suppliers with NDC on PharmaCompass.
Azupharma Brand of Allopurinol Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Azupharma Brand of Allopurinol GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Azupharma Brand of Allopurinol GMP manufacturer or Azupharma Brand of Allopurinol GMP API supplier for your needs.
A Azupharma Brand of Allopurinol CoA (Certificate of Analysis) is a formal document that attests to Azupharma Brand of Allopurinol's compliance with Azupharma Brand of Allopurinol specifications and serves as a tool for batch-level quality control.
Azupharma Brand of Allopurinol CoA mostly includes findings from lab analyses of a specific batch. For each Azupharma Brand of Allopurinol CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Azupharma Brand of Allopurinol may be tested according to a variety of international standards, such as European Pharmacopoeia (Azupharma Brand of Allopurinol EP), Azupharma Brand of Allopurinol JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Azupharma Brand of Allopurinol USP).